tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Insmed: Strong Brensocatib Launch but Pipeline and Payer Uncertainties Keep Risk‑Reward Balanced at Hold
PremiumRatingsInsmed: Strong Brensocatib Launch but Pipeline and Payer Uncertainties Keep Risk‑Reward Balanced at Hold
15d ago
Unusually active option classes on open January 9th
Premium
The Fly
Unusually active option classes on open January 9th
21d ago
Insmed: Strong Brinsupri Launch, Solid Arikayce Performance, and 2026 Catalysts Underpin Buy Rating
Premium
Ratings
Insmed: Strong Brinsupri Launch, Solid Arikayce Performance, and 2026 Catalysts Underpin Buy Rating
21d ago
Insmed sees FY25 Arikayce revenue $433.8M
PremiumThe FlyInsmed sees FY25 Arikayce revenue $433.8M
21d ago
Insmed price target lowered to $157 from $158 at Morgan Stanley
Premium
The Fly
Insmed price target lowered to $157 from $158 at Morgan Stanley
22d ago
Insmed price target lowered to $215 from $223 at UBS
Premium
The Fly
Insmed price target lowered to $215 from $223 at UBS
24d ago
Insmed Stock (INSM) Sinks 18% as Analysts Cut Targets after Trial Failure
PremiumMarket NewsInsmed Stock (INSM) Sinks 18% as Analysts Cut Targets after Trial Failure
1M ago
Midday Fly By: Micron reports Q1 beat, Trump Media to merge with TAE
Premium
The Fly
Midday Fly By: Micron reports Q1 beat, Trump Media to merge with TAE
1M ago
Insmed falls -15.9%
Premium
The Fly
Insmed falls -15.9%
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100